DENOCI 120MG INJECTION

Denoci 120mg Injection is made up of an active component called Denosumab. It is a drug that treats osteoporosis, which is defined by weaker bones. It’s also used to avoid bone problems for patients suffering from certain kinds of cancer, including bone metastases and myeloma. Denoci 120 mg Injection works by blocking a protein known as RANK Ligand, which is involved in the destruction of the bone. Studies have shown it can significantly boost bone density while reducing the risk of fractures in postmenopausal women who have osteoporosis, as well as patients suffering from cancer-related loss of bone. A close monitoring of renal function could be required in patients suffering from moderate impairment in their renal function.
Denoci 120 mg Injection should not be used by people who have a history of hypersensitivity or allergic reaction to the components. A proper vitamin D and calcium intake is essential to maintain the treatment. It is not suitable for use by children and adolescents. Its efficacy and safety in children have yet to be proven. Therefore, its use is not recommended for those who are less than 18 years old. The medication should be utilized carefully in patients with pre-existing hypoparathyroidism, which is characterized by low levels of parathyroid hormone.